This week’s roundup of featured news and local job postings.
MIT and Lyndra developed a controlled release capsule that can last for days! The capsule released a malaria drug for 14 days successfully when administered in a test with pigs. Current extended-release technologies only last for hours. This development can solve the issue of patients not taking their medication as prescribed, resulting in more positive health outcomes and billions of dollars in savings.
New Cambridge based biotech startup, Magenta Therapeutics, receives $48.5 million in funding. Magenta Therapeutics is the first startup to specialize in making bone marrow transplants safer and more available.
Amgen’s experimental drug, Erenumab, is currently leading in the Migraine drug race. The new drug, developed to prevent migraines rather than just relieve symptoms, excelled in drug trials.
Researchers created a stretchable, semi-conducting polymer that could be used in wearable health technologies. The material can stretch to double its size, wrinkle, and even heal!
Pharmaceutical Research Practice Lead – Accenture, Boston, MA
Scientist, Immuno-Oncology – Seres Therapeutics, Cambridge, MA